ESG

Two industry titans are pouring €1 billion into a new joint venture, aiming to capitalize on Europe's booming e-commerce and supply chain shifts.

A Swiss biotech's novel antibiotic has entered human trials with new funding, offering a fresh hope against the world's most dangerous superbugs.

With revenue doubling to ₹22.5 crore and a ₹50 crore target, Relux Electric is accelerating its build-out of a sustainable EV charging network across India.

As new software gives schools full visibility into student iPads, educators gain powerful safety tools, but critics warn of a new era of classroom surveillance.

Optro's inaugural EMEA conference signals a major push into Europe's complex GRC market, focusing on AI governance and transforming risk into opportunity.

Satri-cel, the world's first CAR-T therapy for solid tumors, is set to launch in China, offering a powerful new weapon against advanced stomach cancers.

Aptar Digital Health and Enable Injections are pairing the enFuse® wearable injector with a new digital app to transform self-care for chronic diseases.

As Watts Water Technologies preps its Q1 2026 report, investors watch for clues on market health, strategic growth, and the impact of new regulations.

Following a massive stock surge, Forte Biosciences is raising $150M. The funds are crucial for a pivotal year of clinical trials for its autoimmune drug.

The retailer posts modest annual growth despite a tough Q4, as international gains and efficiency drives offset major headwinds in its Canadian operations.

A Texas firm opens a plant for a non-toxic chemical that boosts oil output and could turn old wells into a new source of critical minerals.

With its lead drug in Phase 3 and a strong Biogen partnership, Stoke Therapeutics prepares to update investors on its disease-modifying Dravet syndrome therapy.

A new study reveals why GLP-1 drugs work for some and not others. 23andMe's research could personalize obesity treatment for millions of patients.

Motorcoach leader Prevost announces a major expansion of its service centers, aiming to reduce downtime and set new industry standards for customer support.

The award-winning Texas vodka is scaling up with a new million-case distillery. Can it maintain its craft soul while aiming for market dominance?

Tekton Research launches its first multi-specialty clinical trial hub in San Antonio, leveraging top physician expertise to tackle diabetes and obesity.

Progressive Grocer’s annual awards name 68 top products, revealing key trends in sustainability, wellness, and global flavors shaping our grocery carts.

Absci will showcase its generative AI drug discovery platform at a key healthcare conference, highlighting its ambitious pipeline for hair loss and endometriosis.

From commercial fleets to combat readiness, Xos targets the defense sector with its grid-independent mobile charging platform for military operations.

After years of development, Solar Roadways is deploying its new SR5 panel at a military base and seeking investment to scale its intelligent pavement.